Goudsmit J - Search Results

1

Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.

Goudsmit J, Weverling GJ, van der Hoek L, de Ronde A, Miedema F, Coutinho RA, Lange JM, Boerlijst MC. Goudsmit J, et al. AIDS. 2001 Nov 23;15(17):2293-301. doi: 10.1097/00002030-200111230-00011. AIDS. 2001. PMID: 11698703

2

Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia.

Goudsmit J, Bogaards JA, Jurriaans S, Schuitemaker H, Lange JM, Coutinho RA, Weverling GJ. Goudsmit J, et al. AIDS. 2002 Mar 29;16(5):791-3. doi: 10.1097/00002030-200203290-00016. AIDS. 2002. PMID: 11964537 No abstract available.

3

Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy.

Boucher CA, Tersmette M, Lange JM, Kellam P, de Goede RE, Mulder JW, Darby G, Goudsmit J, Larder BA. Boucher CA, et al. Among authors: goudsmit j. Lancet. 1990 Sep 8;336(8715):585-90. doi: 10.1016/0140-6736(90)93391-2. Lancet. 1990. PMID: 1975378

4

Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expression.

Reiss P, de Ronde A, Lange JM, de Wolf F, Dekker J, Debouck C, Goudsmit J. Reiss P, et al. Among authors: goudsmit j. AIDS. 1989 Apr;3(4):227-33. doi: 10.1097/00002030-198904000-00006. AIDS. 1989. PMID: 2500956

5

Appearance of predictors of disease progression in relation to the development of AIDS.

de Wolf F, Lange JM, Houweling JT, Mulder JW, Beemster J, Schellekens PT, Coutinho RA, van der Noordaa J, Goudsmit J. de Wolf F, et al. Among authors: goudsmit j. AIDS. 1989 Sep;3(9):563-9. doi: 10.1097/00002030-198909000-00002. AIDS. 1989. PMID: 2571348

6

Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.

de Wolf F, Lange JM, Goudsmit J, Cload P, de Gans J, Schellekens PT, Coutinho RA, Fiddian AP, van der Noordaa J. de Wolf F, et al. Among authors: goudsmit j. Lancet. 1988 Feb 20;1(8582):373-6. doi: 10.1016/s0140-6736(88)91179-8. Lancet. 1988. PMID: 2893187 Clinical Trial.

7

Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection.

Lange JM, Paul DA, de Wolf F, Coutinho RA, Goudsmit J. Lange JM, et al. Among authors: goudsmit j. AIDS. 1987 May;1(1):15-20. AIDS. 1987. PMID: 3122785

8

Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.

Lange JM, de Wolf F, Krone WJ, Danner SA, Coutinho RA, Goudsmit J. Lange JM, et al. Among authors: goudsmit j. AIDS. 1987 Sep;1(3):155-9. AIDS. 1987. PMID: 3126756

9

Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine.

de Gans J, Lange JM, Derix MM, de Wolf F, Eeftinck Schattenkerk JK, Danner SA, Ongerboer de Visser BW, Cload P, Goudsmit J. de Gans J, et al. Among authors: goudsmit j. AIDS. 1988 Feb;2(1):37-40. doi: 10.1097/00002030-198802000-00006. AIDS. 1988. PMID: 3128994

10

Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.

Jurriaans S, Weverling GJ, Goudsmit J, Boogaard J, Brok M, Van Strijp D, Lange J, Koot M, Van Gemen B. Jurriaans S, et al. Among authors: goudsmit j. AIDS Res Hum Retroviruses. 1995 Apr;11(4):473-9. doi: 10.1089/aid.1995.11.473. AIDS Res Hum Retroviruses. 1995. PMID: 7632462 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

582 results

Search Page

Filters